These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16639747)

  • 21. Novel NADPH-binding domain revealed by the crystal structure of aldose reductase.
    Rondeau JM; Tête-Favier F; Podjarny A; Reymann JM; Barth P; Biellmann JF; Moras D
    Nature; 1992 Jan; 355(6359):469-72. PubMed ID: 1734286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells.
    Tammali R; Ramana KV; Singhal SS; Awasthi S; Srivastava SK
    Cancer Res; 2006 Oct; 66(19):9705-13. PubMed ID: 17018629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics and molecular docking studies of kaempferol and its prenylated derivatives as aldose reductase inhibitors.
    Jung HA; Moon HE; Oh SH; Kim BW; Sohn HS; Choi JS
    Chem Biol Interact; 2012 May; 197(2-3):110-8. PubMed ID: 22543015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The structure of Apo R268A human aldose reductase: hinges and latches that control the kinetic mechanism.
    Bohren KM; Brownlee JM; Milne AC; Gabbay KH; Harrison DH
    Biochim Biophys Acta; 2005 May; 1748(2):201-12. PubMed ID: 15769597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A glutathione-specific aldose reductase of Leishmania donovani and its potential implications for methylglyoxal detoxification pathway.
    Rath J; Gowri VS; Chauhan SC; Padmanabhan PK; Srinivasan N; Madhubala R
    Gene; 2009 Jan; 429(1-2):1-9. PubMed ID: 18983902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Docking and molecular dynamics studies toward the binding of new natural phenolic marine inhibitors and aldose reductase.
    Wang Z; Ling B; Zhang R; Suo Y; Liu Y; Yu Z; Liu C
    J Mol Graph Model; 2009 Sep; 28(2):162-9. PubMed ID: 19616461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probing the ultra-high resolution structure of aldose reductase with molecular modelling and noncovalent mass spectrometry.
    Darmanin C; Chevreux G; Potier N; Van Dorsselaer A; Hazemann I; Podjarny A; El-Kabbani O
    Bioorg Med Chem; 2004 Jul; 12(14):3797-806. PubMed ID: 15210146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure of porcine aldehyde reductase holoenzyme.
    el-Kabbani O; Judge K; Ginell SL; Myles DA; DeLucas LJ; Flynn TG
    Nat Struct Biol; 1995 Aug; 2(8):687-92. PubMed ID: 7552731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An anion binding site in human aldose reductase: mechanistic implications for the binding of citrate, cacodylate, and glucose 6-phosphate.
    Harrison DH; Bohren KM; Ringe D; Petsko GA; Gabbay KH
    Biochemistry; 1994 Mar; 33(8):2011-20. PubMed ID: 8117658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure of aldehyde reductase in ternary complex with a 5-arylidene-2,4-thiazolidinedione aldose reductase inhibitor.
    Carbone V; Giglio M; Chung R; Huyton T; Adams J; Maccari R; Ottana R; Hara A; El-Kabbani O
    Eur J Med Chem; 2010 Mar; 45(3):1140-5. PubMed ID: 20036445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aldose reductase as a target for drug design: molecular modeling calculations on the binding of acyclic sugar substrates to the enzyme.
    De Winter HL; von Itzstein M
    Biochemistry; 1995 Jul; 34(26):8299-308. PubMed ID: 7599122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism.
    Crosas B; Hyndman DJ; Gallego O; Martras S; Parés X; Flynn TG; Farrés J
    Biochem J; 2003 Aug; 373(Pt 3):973-9. PubMed ID: 12732097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure of xylose reductase bound to NAD+ and the basis for single and dual co-substrate specificity in family 2 aldo-keto reductases.
    Kavanagh KL; Klimacek M; Nidetzky B; Wilson DK
    Biochem J; 2003 Jul; 373(Pt 2):319-26. PubMed ID: 12733986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a novel polyfluorinated compound as a lead to inhibit the human enzymes aldose reductase and AKR1B10: structure determination of both ternary complexes and implications for drug design.
    Cousido-Siah A; Ruiz FX; Mitschler A; Porté S; de Lera ÁR; Martín MJ; Manzanaro S; de la Fuente JA; Terwesten F; Betz M; Klebe G; Farrés J; Parés X; Podjarny A
    Acta Crystallogr D Biol Crystallogr; 2014 Mar; 70(Pt 3):889-903. PubMed ID: 24598757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insights from modeling the 3D structure of NAD(P)H-dependent D-xylose reductase of Pichia stipitis and its binding interactions with NAD and NADP.
    Wang JF; Wei DQ; Lin Y; Wang YH; Du HL; Li YX; Chou KC
    Biochem Biophys Res Commun; 2007 Jul; 359(2):323-9. PubMed ID: 17544374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystallographic and functional characterization of the fluorodifen-inducible glutathione transferase from Glycine max reveals an active site topography suited for diphenylether herbicides and a novel L-site.
    Axarli I; Dhavala P; Papageorgiou AC; Labrou NE
    J Mol Biol; 2009 Jan; 385(3):984-1002. PubMed ID: 19014949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virtual screening for inhibitors of human aldose reductase.
    Kraemer O; Hazemann I; Podjarny AD; Klebe G
    Proteins; 2004 Jun; 55(4):814-23. PubMed ID: 15146480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 'specificity' pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil.
    Urzhumtsev A; Tête-Favier F; Mitschler A; Barbanton J; Barth P; Urzhumtseva L; Biellmann JF; Podjarny A; Moras D
    Structure; 1997 May; 5(5):601-12. PubMed ID: 9195881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydrogen bonding interactions between aldose reductase complexed with NADP(H) and inhibitor tolrestat studied by molecular dynamics simulations and binding assay.
    Lee YS; Hodoscek M; Kador PF; Sugiyama K
    Chem Biol Interact; 2003 Feb; 143-144():307-16. PubMed ID: 12604217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structure of NADP(H)-dependent 1,5-anhydro-D-fructose reductase from Sinorhizobium morelense at 2.2 A resolution: construction of a NADH-accepting mutant and its application in rare sugar synthesis.
    Dambe TR; Kühn AM; Brossette T; Giffhorn F; Scheidig AJ
    Biochemistry; 2006 Aug; 45(33):10030-42. PubMed ID: 16906761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.